C57BLI10 and C57BL/6 mice (H-2b); B10 congenic mice with f, k, p, q, r, and s H-2 haplotypes; B10 mice with recombinant g2, o2, a, h2, h4, iS, and bql H-2 haplotypes; and B6 mice with major histocompatibility complex (MHC) mutant bml and bml3 (class I) and bml2 (class II) haplotypes were infected intravenously with 4 x 106 CFU of live Mycobacterium bovis BCG and examined by Western immunoblot analysis for serum antibodies against BCG culture filtrate antigens, following a boost injection with live BCG or with BCG culture filtrate. Parental B1O and B6 mice reacted very intensely with three culture filtrate protein bands with estimated molecular masses of 37, 38, and 40 kDa. Response against the 40-kDa protein was stronger following a boost injection with live BCG than following a boost with culture filtrate. Sera from mice with f, p, i5, bml, and bml3 haplotypes reacted strongly, with both the 37-38-and 40-kDa antigens, and sera from mice with q and bql haplotypes showed a somewhat weaker reaction. Sera from mice with r, s, and bml2 haplotypes reacted against the 37-38-kDa antigen but not against the 40-kDa antigen, and sera from mice with the h2 haplotype reacted only with the 40-kDa antigen but not with the 37-38-kDa antigen. Sera from mice with the k, g2, o2, a, and h4 haplotypes showed, at most, a very weak reaction with the 37-38-and 40-kDa antigens. These results demonstrate that MHC genes profoundly affect the antibody repertoire used against culture filtrate antigens in mice infected with live M. bovis BCG. In particular, as shown in mice with the recombinant H-2 haplotype and in class II mutant bml2 mice, the I-A heterodimer controls the recognition of the immunodominant 40-kDa antigen. By using crossed immunoelectrophoresis, this 40-kDa antigen was identified as antigen 88 according to the reference system of Closs et al. for BCG antigens.
Acquired protective immunity against mycobacterial infections is the result of interactions between specifically sensitized T lymphocytes and macrophages harboring the infectious organism (31, 33) . Little is known, however, about the precise antigens involved in protective immunity against such pathogens. On the basis of a generally recognized difference in the efficacy of live and dead mycobacterial vaccines to generate protective immunity (11, 34) , it has been argued that secreted antigens, present in large amounts in mycobacterial culture filtrates (CFs) (3, 16) , rather than structural components may be essential for the induction of protection. In this respect, a number of authors have reported on the potent T-cell-stimulatory properties of whole mycobacterial CF in mice (4), guinea pigs (38) , and humans (12, 22) and of a number of purified CF proteins, such as the 30-32-33-kDa fibronectin-binding antigen 85 (24, 27, 28) and the 38-kDa phosphate-binding glycolipoprotein, also called antigen 78 (37, 39) .
Following intravenous infection with live Mycobacterium bovis BCG, inbred laboratory mice produce substantial amounts of antibodies against these CF proteins (26). We have previously reported that the repertoire of these antibodies is dependent on the mouse genotype, since BALB/c sera react with a wide range of CF antigens but preferentially with the 65-kDa heat shock protein and the 30-32-33-kDa fibronectin-binding protein and C57BL/6 sera demonstrate a * Corresponding author. more restricted antibody response directed predominantly against three CF antigens with estimated molecular masses of 37, 38, and 40 kDa. Analysis of the antibody repertoire in wild house mice (Mus musculus domesticus) has demonstrated a strong individual variation in the recognition pattern of these CF antigens following infection with live BCG (25) .
Antibodies are generally thought to be of little importance in protection against mycobacteria and may even enhance bacterial replication (15, 18) . Nevertheless, a role of immunoglobulins in opsonization of mycobacteria or of certain isotypes in antibody-dependent cell-mediated cytotoxicity cannot be excluded (32) . Moreover, antibody formation against protein antigens is a T-cell-dependent phenomenon, and hence analysis of the antibody repertoire may give more precise information on the type of antigens against which reactive helper T cells are generated in a particular mouse strain. Using BCG-infected B10-congenic mice with different H-2 haplotypes, B10 mice with recombinant H-2 haplotypes, and B6 mice with mutant major histocompatibility complex (MHC) class I and II haplotypes, we analyzed the regulatory control of MHC on antibody formation against BCG CF antigens. We also describe the production of eight new monoclonal antibodies (MAbs) against BCG CF antigens, using spleen cells from BCG-infected mice with the H-2b haplotype. Using two MAbs directed against the immunodominant 40-kDa antigen, we have identified this protein as antigen 88 according to the reference system of Closs et al. (9) for BCG antigens. 
a Nomenclature system of Hansen and Sachs (21 Table 1 . BCG infection. Mice were inoculated intravenously with 0.5 mg (ca. 4 x 106 CFU) of freshly prepared M. bovis BCG GL2 (Pasteur Institute of Brabant) as described previously (26) . At 2 months, they received an intravenous boost injection with 0.5 mg of live BCG or 25 jig of BCG CF. They were sacrificed 4 weeks later. The sera from at least four mice per group were pooled and kept frozen at -20°C until assayed. Although small (quantitative) individual differences could on some occasions be observed in these inbred mice, the overall antibody repertoire was found to be identical for all mice within one strain, enabling the use of pooled sera in this analysis (data not shown).
Antigens. CF antigens were obtained from 14-day-old cultures of M. bovis BCG GL2, grown as a surface pellicle culture on synthetic Sauton medium. Proteins were concentrated by precipitation with ammonium sulfate (80% saturation) (26) .
MAbs. MAbs directed against various CF antigens were prepared by using H-2b spleen cells from BCG-infected C57BL/6 or BALB.B10 mice, rechallenged 4 weeks prior to fusion with a second intravenous inoculation of BCG (0.5 mg) or a boost injection with BCG CF (25 ,g per mouse). Hybridomas were established by fusion with the Sp2-0 myeloma cell line, as described previously (10 sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot analysis were performed as described previously (26) . Briefly, CF antigens were separated under reducing conditions on 12.5% polyacrylamide gels and transferred to-nitrocellulose sheets. Nitrocellulose strips (containing ca. 30 ,ug of CF per strip) were incubated with sera (diluted 1:50) or MAbs (diluted 1:10), and reactivity was analyzed by using peroxidase-conjugated rabbit anti-total-mouse immunoglobulin G (IgG) antibody, a-chloronaphthol, and H202.
CIE. Crossed immunoelectrophoresis (CIE) was performed as described in detail previously (9) . Briefly, BCG culture filtrate was applied in circular wells in the lower gel, alone or together with the respective MAbs. Protein was separated by electrophoresis in one dimension. Next, separated proteins were forced to migrate through the intermediate gel, containing rabbit anti-mouse antibodies, and through the upper gel, containing rabbit anti-BCG antibodies. Precipitate lines were stained with Coomassie brilliant blue, and the control CIE pattern was compared with the MAb-influenced pattern to identify the relevant antigen.
RESULTS
Western blot analysis of anti-CF antibodies in BCG-infected B10 mice with different H-2 haplotypes. We have previously reported (26) that BCG-infected B10 mice react almost exclusively but very intensely with three CF antigens of 37-38 and 40 kDa after a boost injection with live BCG. Antibodies against the 30-32-33-kDa antigen (antigen 85) are hardly detectable in B10 sera, although this antigen is the major protein component of such CFs (26) . We therefore compared antibody reactivity in BCG-infected mice, following a boost injection with live BCG or with purified CF, to determine whether absent reactivity against certain antigens, such as antigen 85, was exclusively controlled by genetic factors or whether it could be modulated by increasing the antigenic dose. Figure 1 shows Western blot patterns of anti-CF antibodies in BCG-infected mice that received a boost injection of live BCG (left lanes) or of total CF protein (right lanes). In most haplotypes, the antibody repertoire was more or less the same after the two types of boost injection, but certain differences could be observed. The 40-kDa protein was always recognized more strongly after boosting with live BCG than after boosting with CF. On the H-2 g2 02 a h2h4 i5bqi other hand, antibodies against the 35-kDa protein, characteristic for the response of about 25% of wild house mice (25) , were observed only in B1O.A (H-2a) mice after challenge with BCG but also appeared in mice with k, p, and r haplotypes after CF challenge. The H-2 haplotype profoundly influenced the antibody repertoire in these B10 congenic mice. Parental B10 mice and B1O.M and B1O.P mice reacted strongly (BlO.Q mice reacted to a lesser extent) against the 37-38-and 40-kDa proteins after BCG challenge. The 40-kDa antigen was not recognized in B1O.P or B1O.Q mice after challenge with culture filtrate. B1O.S and B1O.RIII mice reacted against the 37-38-kDa but not against the 40-kDa protein, and B1O.BR mice did not react against either antigen. BlO.P, B1O .S, and B1O.RIII mice also reacted with the 65-kDa heat shock protein (HSP), whereas B10, BMO.M, B1O .BR, and B1O.Q mice were unreactive against this HSP. An 81-kDa antigen was recognized by sera from B10 and B1O.RIII mice (especially after a boost with CF), and a 22-kDa antigen was recognized only by B10 and B1O.M mice. Finally, a 25-kDa protein and the 30-32-33-kDa protein (antigen 85) were faintly recognized by all sera, after both live BCG and CF boost.
Western blot analysis of anti-CF antibodies in BCG-infected B10 mice with the recombinant MHC haplotype. Analysis of sera from B10 mice with the recombinant MHC haplotype provided further evidence of the remarkable influence of H-2-linked genes on the anti-CF antibody repertoire (Fig. 2) . Here again, the most pronounced differences were observed in the recognition of the 37-38-and 40-kDa antigens. B1O.A(5R) mice reacted strongly (as did B10.MBR mice, albeit to a lesser extent) against the 37-38-and 40-kDa antigens, and the response against the 40-kDa antigen was strongest after a boost with live BCG. B1O.A(2R) mice recognized only the 40-kDa antigen but not the 37-38-kDa antigen. B1O.GD, B10.OH, B1O .A, and B1O.A(4R) mice, finally, showed at most a very weak reaction against the 37-38-and 40-kDa antigens. The 35-kDa antigen was recognized strongly by sera from B1O.A mice (challenged with BCG or CF) and by B1O.A(2R) mice (challenged with CF only). Antibodies against the 81-kDa antigen were observed in B10.OH mice, those against the 65-kDa HSP were observed in B1O.GD mice, and those against the 22-kDa antigen were observed in B10.MBR mice. The 25-and 30-32-33-kDa antigens were again weakly recognized by all sera, after a boost with live BCG or CF. A summary of the reactivities found in Fig. 1 and 2 is given in Table 2 .
Reactivity (Fig. 3) . The response against the 37-38-kDa antigen was not affected in these mutant mice, whereas bml2 mice were also less reactive against the 81-kDa antigen. Reactivity against the 25-and the 30-32-33-kDa antigens was weak in these three strains. Identification of culture filtrate antigens with monoclonal antibodies derived from BCG-infected mice. As reported previously (26), MHC-congenic BALB.B10 mice, presenting the H-2b haplotype on a BALB/c background, reacted as B10 or B6 mice, with strong recognition of both the 37-38-and 40-kDa antigens, whereas BALB/c mice reacted only against the 37-38-kDa protein (Fig. 4, lanes B to D) . Furthermore, BALB.B10 mice reacted against the 22-and 81-kDa antigens in the same way as did B6 mice. On the other hand BALB.B10 mice also reacted strongly against the 65-kDa HSP and against the 30-32-33-kDa fibronectin-binding protein, as did BALB/c mice, indicating that the recognition of these two antigens is not controlled by MHC genes on a BALB/c background. A boost injection of CF in BCGinfected BALB.B10 mice (Fig. 4, lane A) Table 4 and Fig. 4 .
Identification of the 40-kDa antigen in CIE. As shown in Fig. 5 , the use of MAbs 2F8-3 and 2C1-5 enabled us to identify the 40-kDa protein as antigen 88 in classical reference system for BCG antigens (9 25 -kDa antigen, were weakly recognized by sera from all mouse strains tested, whereas antibodies to other CF antigens were found in only some strains and were undetectable in others. Particularly, antibody responses against the 37-38-kDa doublet protein and the 40-kDa protein, i.e., the most immunodominant antigens for parental B10 and B6 mice, varied strongly among different MHC haplotypes. The 37-38-kDa antigen appeared as a doublet protein with a common B-cell epitope on the two components, since all sera and also the MAb 2A1-2 always reacted with the two components in CF. Reactivity against the 40-kDa protein was not linked to the response against the 37-38-kDa antigen, as clearly shown in B10.RIII, B10.S, B10.A(2R), and class II mutant bml2 mice. The highest reactivity against the 40-kDa protein was found in mice with f, p, and b haplotypes. Results with mice with recombinant or mutant MHC haplotypes indicate that the I-A region plays a crucial role in the recognition of this immunodominant antigen. Thus, mice with i5, bml, and bml3 haplotypes, all expressing the b allele in the I-A region, reacted strongly against the 40-kDa protein, whereas the class II mutant bml2 mice recognized this antigen only weakly. B6 mutant mice with the bml2 haplotype have originated as the result of a gene conversion event in which a short stretch of nucleotides from the Ab chain has been replaced by the corresponding and Thr-71--Lys (21). This mutant bm12 sequence is known to be identical with the A k sequence, and, interestingly, k haplotype B1O.BR mice did not react against the 40-kDa antigen either. It is fascinating to observe that such subtle replacement of three amino acids is responsible for the complete abolition of an antibody response to the 40-kDa antiEen, which is extremely immunodominant in the normal H-2 haplotype. Mutant bml2 Ia+ cells have two to three times less surface Ia than B6 cells do, probably because the mutant , chain fails to associate as effectively with its et partner as the wild-type Pi chain does (30) . Therefore, the defective bml2 response against the 40-kDa antigen probably results from a lack of association of the antigenic peptide with the mutant bml2 heterodimer, leading to inefficient antigen presentation. However, the active generation of suppressor T cells in bml2 mutant mice cannot be excluded either (13) . Anyway, these results strongly favor the hypothesis that the bml2 site is a predominant site on Ia for T-cell recognition in B6 mice and, moreover, could indicate that the number of B-and/or T-cell epitopes on the 40-kDa protein is limited.
Using classical CIE with MAbs 2F8-3 and 2C1-5, we were able to identify the 40-kDa antigen as antigen 88 in the Closs et al. reference system for BCG antigens (9) . These MAbs also identify a protein with similar molecular mass in CF from M. tuberculosis, M. avium, and M. kansasii (13a) . Recently, a gene encoding a 40-kDa protein from M. tuberculosis CF was sequenced and identified as encoding an L-alanine dehydrogenase (2), using the HBT10 MAb derived from BALB.B10 mice hyperimmunized with M. tuberculosis CF (29) . Independently, the gene coding for a 40-kDa NADP-dependent alcohol dehydrogenase from M. bovis BCG has recently been identified at the Institute Pasteur van Brabant (36) . MAbs 2F8-3 and 2C1-5 do not show reactivity against either of these two enzymes (kindly given to us by A. Andersen and M. Stelandre) , suggesting that we are dealing with a new antigen that awaits further identification. (Cloning of the corresponding gene is actually in progress.)
The 37-38-kDa doublet has not yet been definitively classified by CIE, but it is clear that this protein doublet is distinct from the well-known phosphate-binding 38-kDa lipoprotein, also called antigen 78 (21a). Moreover, MAb 2A1-2 does not react with the recombinant 38-kDa protein (30a), and no cross-reactivity can be observed in a latex agglutination assay (14) with the well-defined MAbs TB71 and TB72 (a kind gift from J. Ivanyi).
The two MAbs directed against the 40-kDa antigen were both found to be of the IgG2A isotype. Interestingly, switching to this isotype has been associated with active help from the gamma interferon-producing Thl helper T-cell subset population (5, 17) , a subset that we have found to be preferentially activated in BCG-infected mice with the H-2b haplotype (23) . Since the H-2b haplotype is associated with a more efficient protective immunity against mycobacterial infection than the H-2d (23) and H-2k (7) haplotypes are, it can be speculated that recognition of the 40-kDa antigen by IgG2A antibodies may have a certain relevance to resistance to infection. The 40-kDa antigen is present not only in the CF but also in cytoplasmic extract, and it is probably also exposed on the bacterial cell surface, since BCG bacilli dotted on nitrocellulose membranes can capture MAbs 2F8-3 and 2C1-5 (13a). Antibodies against the 40-kDa protein could therefore play a role in opsonization of bacteria or in antibody-dependent cell-mediated cytotoxicity.
Genetic influences on the antibody response have also been found in mice infected intraperitoneally with live M. tuberculosis (6) (1) , strains that were also found to produce very low anti-65-kDa antibody levels when infected with live M. tuberculosis (6) or M. bovis BCG (see above). In this study we have shown that live BCG infection will induce anti-65 kDa HSP antibodies only in B10-congenic mice with p, s, r, and g2 haplotypes. It is also interesting that on a BALB/c background, MHC-linked genes do not seem to have an effect on responsiveness to the 65-kDa HSP, since MHC-congenic BALB.B10 mice expressing the H-2b haplotype reacted against the 65-kDa HSP to the same extent as the BALB/c parental strain did. This finding is reminiscent of our recent observation that BALB/c and BALB.B10 mice also produce more gamma interferon in response to the 65-kDa HSP than B6 mice do (23) . From these results, we can confirm previous statements that both MHC and non-MHC genes influence immune reactivity against the intracellular 65-kDa HSP (1).
The exact mechanism by which MHC class II genes regulate the antibody production against the 40-kDa protein is not known. A number of genes related to antigen processing (coding for transporter-and proteasome-like proteins) and with a certain degree of polymorphism, have been mapped to this region (for a review, see reference 19) . It is possible that these processing genes influence the variation in antibody repertoire, as we have reported here. Also, the expression of certain class II alleles may exert a direct immune response effect on the antibody repertoire, through variations in the efficiency of epitope presentation by the various haplotypes. The results obtained with B6.C-H-2bm12 mice do indicate that this is indeed the case. As demonstrated by the reactivity in B10.A(2R) and B10.MBR mice, the b or q allele in the D region was also associated with some degree of recognition of the 40-kDa protein in I-Ak mice, albeit to a lesser extent than the b allele in I-A region was. It is known that MHC class I restricted cytotoxic and suppressor CD8+ T cells are capable of producing cytokines such as gamma interferon and interleukin-4, respectively (35) , which may in turn influence antibody production either directly or through increases of class II MHC antigen expression on antigen-presenting macrophages or B cells.
Finally, although all mouse strains used in this study can be classified as susceptible, their development of protective immunity is clearly influenced by MHC (7, 23 ; unpublished data), and this may well determine the quantitative availability of mycobacterial antigens following boost injection with live BCG. In this respect it is interesting that antibody responses to the 40-and 65-kDa antigens (which are only weakly present in CF) were generally higher after a boost with live BCG than with CF, whereas responses against the 35-kDa antigen (present as a well-detected protein band in these CF) were higher after a boost with CF than with live BCG. On the other hand, reactivity against the major CF protein, the 30-32-33-kDa antigen, was similar for both types of boost. Clearly, more work is needed to elucidate the complex control mechanisms by which MHC influences the antibody repertoire against BCG CF antigens.
